BRAF and metastatic melanoma: We report another case of interstitial nephritis related to these drugs.<h4>Case</h4>A 37-year-old man diagnosed with metastatic melanoma (BRAF V600E mutation) who developed acute interstitial nephritis 5 years into his treatment with combination dabrafenib plus trametinib therapy.